Skip to content
thispeptide

Bliv

Bliv separates its technology platform from named state-specific medical groups. Its GLP-1 page advertises an online assessment, while prices remain qualified by plan structure and eligibility.

Review by Molly Ward, goal-guide writer · Updated October 2026

The short version

Bliv’s consent makes the clinical responsibility more traceable than its short marketing page alone suggests. Before relying on the convenience claims, confirm the treating clinician, whether a live assessment is needed and the precise preparation being prescribed. The app’s AI assistant does not replace that conversation.

Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Bliv is a digital health platform operated by Metabody Services, LLC. It offers access to GLP-1 evaluations alongside other wellness and prescription services. Its GLP-1 landing page names semaglutide and tirzepatide but qualifies the price cards by plan structure and eligibility. A broad menu mentioning peptide therapy does not establish a current purchasable formulation or regimen for every peptide discussed elsewhere.

What Bliv prescribes, by goal

Weight

  • SemaglutideFDA-approved

    Listed by the seller; no price we hold.

    • TirzepatideFDA-approved

      Listed by the seller; no price we hold.

      The GLP-1 page names semaglutide and tirzepatide. Its short price cards do not establish the dose, supplied amount or treatment schedule for every applicant. The consent acknowledges that some prescriptions may be compounded and explains that these are not generic equivalents of approved brands. Get the product, formulation and reason for any compounding in the clinician’s own plan.

      Who prescribes

      A licensed clinician

      The consent identifies a network of independent practices, including Metabody Medical P.A. Separate entities cover California, New York and New Jersey, Kansas, Colorado and Texas. It says the responsible clinician’s name and credentials appear in the app. That identifies the practice structure without promising a particular clinician before enrollment. The medical groups choose the pharmacy, with details on the label and order record. The consent does not identify one dispensing facility for every patient.

      The GLP-1 page promotes a questionnaire reviewed by a US-licensed provider and says phone or video visits are not required for that advertised pathway. The broader consent describes remote care, clinician judgment and the limitations of the information supplied online. Give a complete medical history and ask how the team handles a case needing more assessment. The contract also describes an AI assistant used for information and care-team support. It expressly reserves clinical decisions, including prescribing, to a licensed clinician.

      Are labs required?

      Assessment-specific testing

      The broader platform provides access to laboratory services. The reviewed GLP-1 page does not establish a required baseline panel or an included testing allowance. Ask what information the prescriber needs before treatment and who pays for any testing. A connected health profile is not evidence that a particular laboratory result has been reviewed.

      Ready to start with Bliv?

      Prices and plans are set on the seller's own site.

      What it claims, and what it cites

      The landing page uses customer counts, approval-speed language and general weight-loss benefits. Those statements do not establish an expected result from the exact medicine supplied to a new patient. The consent is more useful on one important point: AI-generated answers can be incomplete, and the licensed clinician makes the actual treatment decision. Treat that distinction as a reason to confirm important advice with the human care team, not as evidence that an automated tool has evaluated safety.

      Other products and treatment claims

      Unspecified peptide-therapy menu
      The reviewed GLP-1 page and consent do not establish a current compound, route and supply for an additional peptide prescription.

      How it bills

      Several starting figures appear in the marketing page, with eligibility and plan-structure qualifications. They do not establish one standing no-commitment monthly bill. Paid subscriptions renew until canceled, and the contract says the applicable price, frequency and minimum term must be disclosed at purchase. Canceling platform access does not necessarily stop a pending prescription, lab order or shipment. Read those separate obligations before paying.

      For and against

      • For: State-specific medical practices named
      • For: Clinician identity available in the app
      • For: Human responsibility for prescribing explicit
      • For: Subscription cancellation and order-refund boundaries described
      • Against: Assigned pharmacy remains order-specific
      • Against: Headline figures need a plan-specific quote
      • Against: No common laboratory package established
      • Against: Marketing convenience does not establish individual clinical suitability

      The evidence behind what it sells

      Right for

      Someone comfortable with an online assessment who wants named medical practices and will confirm the clinical and payment details before subscribing.

      Look elsewhere if

      Someone who expects a guaranteed prescription, a named dispensing pharmacy before asking, or a complete monthly quote from the smallest advertising figure.

      Other sellers for weight

      Bliv

      Frequently asked questions

      Does Bliv’s AI assistant prescribe?
      The consent says clinical decisions, including prescribing, are made by a licensed clinician. AI-generated information should be confirmed with that clinician when it matters to care.
      Who is responsible for medical treatment?
      The consent lists independent Metabody medical practices by state. Metabody Services, LLC operates the technology and management platform rather than providing the medical care itself.
      Is the pharmacy identified before enrollment?
      The reviewed consent says the dispensing pharmacy’s details appear on the label and order record. Ask the care team to identify the actual facility before relying on a general pharmacy-network description.

      Sources

      • GLP-1 program and qualified headline prices
      • Platform, billing and cancellation contract
      • Medical groups and telehealth consent

      See what Bliv prescribes today

      Bliv sets its own prices, plans and the states it serves. Check them before you start.

      Written by Molly Ward from Bliv’s own public pages, against the published methodology. No outcome is claimed first-hand and no score is given. A partnership never changes what this page says; see how the site is paid.